Protocol PT 11-29: Randomized, Open-label, Cross-over Pilot Study to Evaluate and Compare Two Omeprazole Containing Products for Relief of Frequent Heartburn

Trial Profile

Protocol PT 11-29: Randomized, Open-label, Cross-over Pilot Study to Evaluate and Compare Two Omeprazole Containing Products for Relief of Frequent Heartburn

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Mar 2015

At a glance

  • Drugs Omeprazole (Primary) ; Omeprazole/sodium bicarbonate (Primary)
  • Indications Heartburn
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 24 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top